Cardlytics (CDLX) Stock Forecast, Price & News

Cardlytics (NASDAQ:CDLX) Frequently Asked Questions

Is Cardlytics a buy right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cardlytics in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Cardlytics stock.
View analyst ratings for Cardlytics or view top-rated stocks.

When is Cardlytics' next earnings date?

Cardlytics is scheduled to release its next quarterly earnings announcement on Tuesday, August 2nd 2022.
View our earnings forecast for Cardlytics.

How were Cardlytics' earnings last quarter?

Cardlytics, Inc. (NASDAQ:CDLX) announced its quarterly earnings results on Monday, May, 2nd. The company reported ($0.75) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($1.11) by $0.36. The firm earned $67.93 million during the quarter, compared to analyst estimates of $65.84 million. Cardlytics had a negative net margin of 25.06% and a negative trailing twelve-month return on equity of 13.81%. During the same period in the prior year, the firm posted ($0.59) earnings per share.
View Cardlytics' earnings history.

What guidance has Cardlytics issued on next quarter's earnings?

Cardlytics issued an update on its second quarter 2022 earnings guidance on Monday, May, 9th. The company provided EPS guidance of for the period. The company issued revenue guidance of $73.00 million-$80.00 million, compared to the consensus revenue estimate of $74.68 million.

What price target have analysts set for CDLX?

3 brokerages have issued 1 year price targets for Cardlytics' shares. Their forecasts range from $50.00 to $72.00. On average, they anticipate Cardlytics' stock price to reach $60.67 in the next year. This suggests a possible upside of 105.7% from the stock's current price.
View analysts' price targets for Cardlytics or view top-rated stocks among Wall Street analysts.

Who are Cardlytics' key executives?

Cardlytics' management team includes the following people:

• Mr. Scott D. Grimes, Co-Founder & Exec. Chairman (Age 59, Pay $3.31M)
• Ms. Lynne Marie Laube, Co-Founder, CEO & Director (Age 52, Pay $727.13k) (LinkedIn Profile)
• Mr. Andrew C. Christiansen, Chief Financial Officer (Age 43, Pay $540.28k) (LinkedIn Profile)
• Mr. Kirk L. Somers Esq., Chief Legal & Privacy Officer and Sec. (Age 57, Pay $512.61k)
• Mr. Peter Chan, Chief Technology Officer
• Mr. Peter Gleason, Chief Admin. Officer (Age 53)
• Angie Amberg, Head of Brand Marketing & Communications
• Mr. Peter Davies, Head of Sales Strategy & Operations
• Mr. Craig Snodgrass, Chief Data Officer (Age 49)
• Mr. Jared Luskin, Sr. VP of Growth Verticals

What is Scott Grimes' approval rating as Cardlytics' CEO?

63 employees have rated Cardlytics CEO Scott Grimes on Glassdoor.com. Scott Grimes has an approval rating of 86% among Cardlytics' employees.

Who are some of Cardlytics' key competitors?

Some companies that are related to Cardlytics include Wix.com (WIX), DoubleVerify (DV), Bumble (BMBL), Tripadvisor (TRIP), Internet Initiative Japan (IIJIY), KnowBe4 (KNBE), Sportradar Group (SRAD), MassRoots (MSRT), Chindata Group (CD), Sabre (SABR), Cyxtera Technologies (CYXT), Rackspace Technology (RXT), Integral Ad Science (IAS), Momentive Global (MNTV) and Dada Nexus (DADA).
View all of CDLX's competitors.

What other stocks do shareholders of Cardlytics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardlytics investors own include NVIDIA (NVDA), Square (SQ), DocuSign (DOCU), Advanced Micro Devices (AMD), Caterpillar (CAT), Walt Disney (DIS), Alibaba Group (BABA), Trade Desk (TTD), QUALCOMM (QCOM) and Twilio (TWLO).

When did Cardlytics IPO?

(CDLX) raised $76 million in an IPO on Friday, February 9th 2018. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. BofA Merrill Lynch and J.P. Morgan served as the underwriters for the IPO and Wells Fargo Securities, SunTrust Robinson Humphrey, Raymond James and KeyBanc Capital Markets were co-managers.

What is Cardlytics' stock symbol?

Cardlytics trades on the NASDAQ under the ticker symbol "CDLX."

Who are Cardlytics' major shareholders?

Cardlytics' stock is owned by many different retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (8.58%), BlackRock Inc. (6.95%), JPMorgan Chase & Co. (6.17%), Baillie Gifford & Co. (3.13%), State Street Corp (1.90%) and Bank of New York Mellon Corp (1.82%). Company insiders that own Cardlytics stock include Andrew Christiansen, Bryce Youngren, Clifford Sosin, David Leslie Adams, David Thomas Evans, John L Jr Klinck, John V Balen, John V Balen, Kirk Somers, Lynne Marie Laube, S Aimee Lapic, Scott D Grimes, Scott D Grimes and Tony Weisman.
View institutional ownership trends for Cardlytics.

Which major investors are selling Cardlytics stock?

CDLX stock was sold by a variety of institutional investors in the last quarter, including Lazard Asset Management LLC, Teton Advisors Inc., JPMorgan Chase & Co., Gamco Investors INC. ET AL, Renaissance Technologies LLC, Bank of New York Mellon Corp, Endeavour Capital Advisors Inc., and BlackRock Inc.. Company insiders that have sold Cardlytics company stock in the last year include Andrew Christiansen, Kirk Somers, Lynne Marie Laube, S Aimee Lapic, and Scott D Grimes.
View insider buying and selling activity for Cardlytics or view top insider-selling stocks.

Which major investors are buying Cardlytics stock?

CDLX stock was purchased by a variety of institutional investors in the last quarter, including Baillie Gifford & Co., Goldman Sachs Group Inc., Canada Pension Plan Investment Board, Integrated Advisors Network LLC, Personal Capital Advisors Corp, Landscape Capital Management L.L.C., Vanguard Group Inc., and Jennison Associates LLC. Company insiders that have bought Cardlytics stock in the last two years include Clifford Sosin, and John V Balen.
View insider buying and selling activity for Cardlytics or or view top insider-buying stocks.

How do I buy shares of Cardlytics?

Shares of CDLX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cardlytics' stock price today?

One share of CDLX stock can currently be purchased for approximately $29.49.

How much money does Cardlytics make?

Cardlytics has a market capitalization of $1.01 billion and generates $267.12 million in revenue each year. The company earns $-128.57 million in net income (profit) each year or ($2.240010) on an earnings per share basis.

How many employees does Cardlytics have?

Cardlytics employs 591 workers across the globe.

What is Cardlytics' official website?

The official website for Cardlytics is www.cardlytics.com.

How can I contact Cardlytics?

Cardlytics' mailing address is 675 PONCE DE LEON AVENUE NE SUITE 6000, ATLANTA GA, 30308. The company can be reached via phone at (888) 798-5802 or via email at [email protected].